• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts.

作者信息

Rabbani S A, Rajwans N, Achbarou A, Murthy K K, Goltzman D

机构信息

Department of Medicine, McGill University, Montreal, Quebec, Canada.

出版信息

FEBS Lett. 1994 Jan 24;338(1):69-74. doi: 10.1016/0014-5793(94)80118-5.

DOI:10.1016/0014-5793(94)80118-5
PMID:8307160
Abstract

A rat urokinase receptor (uPAR) cDNA fragment was amplified by RT-PCR from RNA of the rat osteoblastic cell line CFK-1. Using this DNA species as a hybridization probe two rat uPAR cDNAs were isolated from a CFK-1 cDNA library. These two cDNAs encode an identical uPAR protein except for a single base mutation which results in the substitution of cysteine to serine at amino acid 71 in one variant. PCR analysis of rat genomic DNA revealed the presence of an additional uPAR arising from alternate splicing which is expressed in a variety of tissues. These studies provide the tools for examining uPAR function in fibrinolysis, tumor invasion and metastasis in the rat and for identifying the mechanism of species specificity in uPA actions.

摘要

相似文献

1
Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts.
FEBS Lett. 1994 Jan 24;338(1):69-74. doi: 10.1016/0014-5793(94)80118-5.
2
cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.尿激酶氨基末端片段的cDNA转染有效抑制癌细胞侵袭和转移。
DNA Cell Biol. 2001 May;20(5):297-305. doi: 10.1089/104454901750232490.
3
Differential binding of urokinase and peptide antagonists to the urokinase receptor: evidence from characterization of the receptor in four primate species.尿激酶及肽拮抗剂与尿激酶受体的差异性结合:来自四种灵长类动物受体特性研究的证据
Biol Chem. 2001 Mar;382(3):435-42. doi: 10.1515/BC.2001.053.
4
The structure of the urokinase-type plasminogen activator receptor gene.尿激酶型纤溶酶原激活物受体基因的结构
Blood. 1994 Aug 15;84(4):1151-6.
5
An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator.人尿激酶型纤溶酶原激活剂受体的一种可变剪接mRNA变体。
FEBS Lett. 1993 Jul 12;326(1-3):69-74. doi: 10.1016/0014-5793(93)81763-p.
6
A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.尿激酶生长因子结构域与2型纤溶酶原激活物抑制剂的杂合蛋白可抑制尿激酶活性,并与尿激酶受体结合。
Eur J Biochem. 1992 Jul 1;207(1):177-83. doi: 10.1111/j.1432-1033.1992.tb17035.x.
7
Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.人尿激酶型纤溶酶原激活剂受体结合区域的系统突变分析
Eur J Biochem. 1996 May 1;237(3):743-51. doi: 10.1111/j.1432-1033.1996.0743p.x.
8
Plasminogen activator system in osteoclasts.
J Bone Miner Res. 1997 May;12(5):761-8. doi: 10.1359/jbmr.1997.12.5.761.
9
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).环[19,31][D-半胱氨酸19]-尿激酶型纤溶酶原激活剂19-31是尿激酶型纤溶酶原激活剂与其受体(CD87)相互作用的强效竞争性拮抗剂。
Biol Chem. 2001 Aug;382(8):1197-205. doi: 10.1515/BC.2001.150.
10
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.尿激酶型纤溶酶原激活剂在缺乏其受体或组织型纤溶酶原激活剂的情况下对纤维蛋白清除有效。
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5899-904. doi: 10.1073/pnas.93.12.5899.

引用本文的文献

1
The plasminogen activation system and the regulation of catecholaminergic function.纤溶酶原激活系统与儿茶酚胺能功能的调节。
J Biomed Biotechnol. 2012;2012:721657. doi: 10.1155/2012/721657. Epub 2012 Oct 14.
2
Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.实验性糖尿病通过一种涉及酪氨酸硝化以及血管内皮生长因子和尿激酶型纤溶酶原激活剂受体表达增加的机制,导致血视网膜屏障破坏。
Am J Pathol. 2003 Jun;162(6):1995-2004. doi: 10.1016/S0002-9440(10)64332-5.
3
The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.
尿激酶型纤溶酶原激活物受体(UPAR)在PC12嗜铬细胞瘤细胞中优先由神经生长因子诱导产生,并且是神经生长因子驱动分化所必需的。
J Neurosci. 2000 Jan 1;20(1):230-9. doi: 10.1523/JNEUROSCI.20-01-00230.2000.
4
Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor.脑肿瘤的蛋白水解作用与侵袭性:尿激酶型纤溶酶原激活物受体的作用
J Neurooncol. 1994;22(2):153-60. doi: 10.1007/BF01052890.